113 related articles for article (PubMed ID: 8344085)
1. [Effect of nylestriol on postmenopausal uterine endometrium].
Liu JL
Zhonghua Fu Chan Ke Za Zhi; 1993 Feb; 28(2):76-8, 122. PubMed ID: 8344085
[TBL] [Abstract][Full Text] [Related]
2. Prospective double-blind study of CEE3 in peri- and postmenopausal women: effects on bone loss and lipoprotein lipids.
Cheng GJ; Liu JL; Zhang Q; Ye HF; Wang ZQ; Pan HP
Chin Med J (Engl); 1992 Nov; 105(11):929-33. PubMed ID: 1304463
[TBL] [Abstract][Full Text] [Related]
3. Bleeding pattern and endometrial changes during continuous combined hormone replacement therapy. The Ogen/Provera Study Group.
Nand SL; Webster MA; Baber R; O'Connor V
Obstet Gynecol; 1998 May; 91(5 Pt 1):678-84. PubMed ID: 9572210
[TBL] [Abstract][Full Text] [Related]
4. Nylestriol replacement therapy in postmenopausal women. A three-year prospective study.
Cheng GJ; Liu JL; Zhang Q; Fan W; Ye HF; Wang ZQ; Pan HP
Chin Med J (Engl); 1993 Dec; 106(12):911-6. PubMed ID: 8198628
[TBL] [Abstract][Full Text] [Related]
5. Endometrial histology and bleeding patterns after 8 years of continuous combined estrogen and progestogen therapy in postmenopausal women.
Leather AT; Savvas M; Studd JW
Obstet Gynecol; 1991 Dec; 78(6):1008-10. PubMed ID: 1658699
[TBL] [Abstract][Full Text] [Related]
6. Endometrial histology and bleeding patterns in menopausal women treated with estrogen and continuous or cyclic progestin.
Bewtra C; Kable WT; Gallagher JC
J Reprod Med; 1988 Feb; 33(2):205-8. PubMed ID: 2832598
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
Dahmoun M; Odmark IS; Risberg B; Karlsson MG; Pavlenko T; Bäckström T
Maturitas; 2004 Oct; 49(2):114-23. PubMed ID: 15474755
[TBL] [Abstract][Full Text] [Related]
8. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
[TBL] [Abstract][Full Text] [Related]
9. The effect of low dose nylestriol-levonorgestrel replacement therapy on bone mineral density in women with postmenopausal osteoporosis.
Liao EY; Luo XH; Deng XG; Wu XP; Liao HJ; Wang PF; Mao JP; Zhu XP; Huang G; Wei QY
Endocr Res; 2003 May; 29(2):217-26. PubMed ID: 12856809
[TBL] [Abstract][Full Text] [Related]
10. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
Langer RD; Landgren BM; Rymer J; Helmond FA;
Am J Obstet Gynecol; 2006 Nov; 195(5):1320-7. PubMed ID: 16875644
[TBL] [Abstract][Full Text] [Related]
11. Treatment of premenopausal endometrial hyperplasia by a combination of a long-acting estrogen and a cyclic progestogen.
Ricciardi I; Bertorello G; Bruni G; Cali A; Imparato E; Sallusto A
Curr Ther Res Clin Exp; 1973 Jul; 15(7):402-16. PubMed ID: 4198302
[No Abstract] [Full Text] [Related]
12. Continuous combined piperazine oestrone sulphate and medroxyprogesterone acetate hormone replacement therapy--a study of bleeding pattern, endometrial response, serum lipid and bone density changes.
Nand SL; Webster MA; Wren BG
Aust N Z J Obstet Gynaecol; 1995 Feb; 35(1):92-6. PubMed ID: 7772012
[TBL] [Abstract][Full Text] [Related]
13. Relationship between circulating estradiol levels, body mass index, and breakthrough bleeding in postmenopausal women receiving hormone replacement therapy.
Büyük E; Gürler A; Erenus M
Menopause; 1998; 5(1):24-7. PubMed ID: 9689191
[TBL] [Abstract][Full Text] [Related]
14. Endometrial safety and bleeding pattern during a five-year treatment with long-cycle hormone therapy.
Odmark IS; Bixo M; Englund D; Risberg B; Jonsson B; Olsson SE
Menopause; 2005; 12(6):699-707. PubMed ID: 16278613
[TBL] [Abstract][Full Text] [Related]
15. [A prospective study of nylestriol on plasma lipids in postmenopausal women].
Cheng GJ
Zhonghua Fu Chan Ke Za Zhi; 1991 Nov; 26(6):349-51, 387-8. PubMed ID: 1804605
[TBL] [Abstract][Full Text] [Related]
16. [Bone metabolism in postmenopausal women and after estrogen treatment].
Song SJ
Zhonghua Fu Chan Ke Za Zhi; 1993 Feb; 28(2):79-81, 122. PubMed ID: 8344086
[TBL] [Abstract][Full Text] [Related]
17. Assessment of less than monthly progestin therapy in postmenopausal women given estrogen replacement.
Williams DB; Voigt BJ; Fu YS; Schoenfeld MJ; Judd HL
Obstet Gynecol; 1994 Nov; 84(5):787-93. PubMed ID: 7936513
[TBL] [Abstract][Full Text] [Related]
18. Endometrial responses to transdermal estradiol in postmenopausal women.
Whitehead MI; Padwick ML; Endacott J; Pryse-Davies J
Am J Obstet Gynecol; 1985 Aug; 152(8):1079-84. PubMed ID: 4025456
[TBL] [Abstract][Full Text] [Related]
19. Is the timing of withdrawal bleeding a guide to endometrial safety during sequential oestrogen-progestagen replacement therapy? UK Continuous Combined HRT Study Investigators.
Sturdee DW; Barlow DH; Ulrich LG; Wells M; Gydesen H; Campbell M; O'Brien K; Vessey M
Lancet; 1994 Oct; 344(8928):979-82. PubMed ID: 7934429
[TBL] [Abstract][Full Text] [Related]
20. Endometrial effects of tibolone.
Archer DF; Hendrix S; Gallagher JC; Rymer J; Skouby S; Ferenczy A; den Hollander W; Stathopoulos V; Helmond FA
J Clin Endocrinol Metab; 2007 Mar; 92(3):911-8. PubMed ID: 17192288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
